reports
Integra LifeSciences Reports First Quarter 2025 Financial Results
Integra LifeSciences Reports First Quarter 2025 Financial Results PRINCETON, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2025. First Quarter 2025 Highlights First quarter revenues of $382.7 million increased 3.7% on a reported basis and decreased 3.5% on an organic basis compared to the prior year. First quarter GAAP earnings per diluted share of $(0.33), compared to $(0.04) in the prior year; adjusted earnings per diluted share of $0.41, compared to $0.55...
Integra LifeSciences to Host First Quarter 2025 Financial Results Conf...
Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025 PRINCETON, N.J., April 18, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: IART), a leading global medical technology company, will release first quarter 2025 financial results on Monday, May 5, 2025, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at . For those planning to participate on the call, register to receive dial-in detail...
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthc...
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference PRINCETON, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: IART), a leading global medical technology company, announced today that Mojdeh Poul, chief executive officer and Lea Knight, chief financial officer will present at the 35th Annual Oppenheimer Healthcare MedTech & Services Conference on March 17, 2025 at 10:00am ET. A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at . About Integra LifeSciencesAt Integra LifeScien...
Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financi...
Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance PRINCETON, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Reported revenues were $442.6 million, representing an increase of 11.5% on a reported basis and an increase of 3.5% on an organic basis compared to the fourth quarter 2023. GAAP earnings per diluted share were $0.25, compared to $0.25 in the fourth quarter 2023. Adjusted earnings per dilut...
Integra LifeSciences to Host Fourth Quarter and Full Year 2024 Financi...
Integra LifeSciences to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on February 25, 2025 PRINCETON, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2024 financial results on Tuesday, February 25, 2025, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at . For those planning to participate on...
- Dave Nicoski
- Ross LaDuke
TWI TITAN INTERNATIONAL INC.
TRIP TRIPADVISOR INC.
TITN TITAN MACHINERY
SLP SIMULATIONS PLUS
RYI RYERSON HOLDING CORPORATION
QCOM QUALCOMM INC
PCRX PACIRA BIOSCIENCES INC.
MOS MOSAIC COMPANY
J7Z JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
IVZ INVESCO LTD.
IART INTEGRA LIFESCIENCES HOLDINGS CORPORATION
DLTR DOLLAR TREE INC.
DDD 3D SYSTEMS CORPORATION
CERS CERUS CORP.
AVD AMERICAN VANGUARD
ANIP ANI PHARMACEUTICALS INC.
AGCO AGCO CORPORATION
UPS UNITED PARCEL SERVICE INC. CLASS B
OSTK OVERSTOCK.COM INC.
GDEN GOLDEN ENTERTAINMENT
FRX_CN FENNEC PHARMACEUTICALS
ODEL.N0000 ODEL PLC
BRKS BROOKS AUTOMATION INC.
CCV COUNTERPATH
TDC TERADATA CORPORATION
BHF BRIGHTHOUSE FINANCIAL INC.
ZS ZSCALER INC.
TENB TENABLE HOLDINGS
SIBN SI-BONE
PINS PINTEREST INC. CLASS A
VIAC VIACOMCBS INC. CLASS B
ORIC ORIC PHARMACEUTICALS
THRY THRYV HOLDINGS
CERT CERTARA
ONTF ON24
SMTI SANARA MEDTECH
SDGR SCHRODINGER
COUR COURSERA INC
BBWI BATH & BODY WORKS INC
DH DEFINITIVE HEALTHCARE CORP
VERV VERVE THERAPEUTICS INC
PTLO PORTILLOS INC
DCGO DOCGO INC
EHAB ENHABIT INC
SVV SAVERS VALUE VILLAGE INC
QIPT PATIENT HOME MONITORING CORP
HUM HAMILTON U.S. MID-CAP FINANCIALS ETF
CXM SPRINKLR INC
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
S&P 500 Testing Prior Breakout Level DeepSeek appears to have turned the chatbot market upside-down, putting pressure on AI-linked stocks. While the dust has yet to settle, the good news is that the selloff has been largely contained to these AI-linked stocks. The rest of the market did not seem to care; the equal-weighted S&P 500 was roughly flat yesterday. Additionally, market dynamics remain healthy, with Treasury yields, the U.S. dollar (DXY), and WTI crude oil continuing to move lower, and...
SYK STRYKER CORPORATION
GBX GREENBRIER COMPANIES INC.
TRN TRINITY INDUSTRIES INC.
MMSI MERIT MEDICAL SYSTEMS INC.
MDT MEDTRONIC PLC
ISRG INTUITIVE SURGICAL INC.
INGN INOGEN INC.
IART INTEGRA LIFESCIENCES HOLDINGS CORPORATION
GMED GLOBUS MEDICAL INC CLASS A
CRY CRYOLIFE INC.
PEN PENUMBRA INC.
BSX. BELO SUN MINING CORP.
SIBN GAZPROM NEFT PJSC
GATX GATX CORPORATION
RAIL FREIGHTCAR AMERICA INC.
WAB WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORPORATION
OFIX ORTHOFIX MEDICAL INC.
ECOR ELECTROCORE INC.
- Dave Nicoski
- Ross LaDuke
ZBH ZIMMER BIOMET HOLDINGS INC.
SLB.N SCHLUMBERGER NV
CNHI CNH INDUSTRIAL NV
WBA WALGREENS BOOTS ALLIANCE INC
ULTA ULTA BEAUTY INC
SLP SIMULATIONS PLUS
PCRX PACIRA BIOSCIENCES INC.
PBF PBF ENERGY INC. CLASS A
IART INTEGRA LIFESCIENCES HOLDINGS CORPORATION
HXL HEXCEL CORPORATION
DAN DANA INCORPORATED
CVI CVR ENERGY INC.
AGCO AGCO CORPORATION
ACAD ACADIA PHARMACEUTICALS INC.
ALV ALLIANZ SE
MUR MURPHY OIL CORPORATION
BRKS BROOKS AUTOMATION INC.
HP HELMERICH & PAYNE INC.
PTEN PATTERSON-UTI ENERGY INC.
VLO VALERO ENERGY CORPORATION
HI HILLENBRAND INC.
INGR-R-A INGRA D.D.
EYE NATIONAL VISION HOLDINGS
CPRI CAPRI HOLDINGS LIMITED
TW TRADEWEB MARKETS INC. CLASS A
REEMF RARE ELEMENT RESOURCES
NVST ENVISTA HOLDINGS
PGNY PROGYNY
CERT CERTARA
VAL VALARIS LTD
BBWI BATH & BODY WORKS INC
CIVI CIVITAS RESOURCES INC
INVX INNOVEX INTERNATIONAL INC
Integra LifeSciences Launches Integra Institute for Healthcare Profess...
Integra LifeSciences Launches Integra Institute for Healthcare Professionals (HCPs) New global medical education platform offers digital tools to keep HCPs at the forefront of medical knowledge PRINCETON, N.J., Jan. 14, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: IART), a leading global medical technology company, today announced the launch of its global medical education platform . This new digital resource is designed to elevate Integra’s medical education offerings in surgical, neurologic, ENT and regenerative care by enhancing professional development through a wealth of on-demand learning ...
Integra’s DuraSeal® Dural Sealant Saves Healthcare Costs According to ...
Integra’s DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research The health economic analysis, conducted in five European countries, shows that hospitals can reduce costs of cerebrospinal fluid leaks after posterior cranial fossa surgeries by using DuraSeal dural sealant instead of fibrin glue PRINCETON, N.J., Nov. 13, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: IART), a leading global medical technology company, today announced the publication of a new economic study, “PEG hydrogel sealant versus fibrin g...
Integra LifeSciences Reports Third Quarter 2024 Financial Results
Integra LifeSciences Reports Third Quarter 2024 Financial Results PRINCETON, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2024. Third Quarter 2024 Highlights Third quarter revenues of $380.8 million decreased 0.4% on a reported basis and 8.6% on an organic basis compared to the prior year. Revenue decreased 10.3% on an organic basis excluding Boston.Third quarter GAAP earnings per diluted share of $(0.14), compared to $0.24 in the prior year; adjusted ...
Integra LifeSciences Announces Appointment of Mojdeh Poul as President...
Integra LifeSciences Announces Appointment of Mojdeh Poul as President and Chief Executive Officer A proven healthcare executive with deep global expertise and a distinguished record in business strategy and execution, portfolio transformation, value-creating innovation, commercial excellence, and leadership development PRINCETON, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- (Nasdaq:IART), a leading global medical technology company, today announced that its board of directors has appointed Mojdeh Poul as the new president and chief executive officer, effective January 6, 2025. Ms. Poul wil...
Integra LifeSciences to Host Third Quarter 2024 Financial Results Conf...
Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024 PRINCETON, N.J., Oct. 14, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: IART), a leading global medical technology company, will release third quarter 2024 financial results on Monday, November 4, 2024, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at . For those planning to participate on the call, register to receive dial-...
Integra LifeSciences to Present at the 22nd Annual Morgan Stanley Heal...
Integra LifeSciences to Present at the 22nd Annual Morgan Stanley Healthcare Conference PRINCETON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the Morgan Stanley Healthcare conference on September 6, 2024 at 10:45am ET. A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at . About Integra LifeSciencesAt Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatm...
Integra LifeSciences to Present at the 2024 Wells Fargo Healthcare Con...
Integra LifeSciences to Present at the 2024 Wells Fargo Healthcare Conference PRINCETON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer, will present at the Wells Fargo Healthcare conference on September 4, 2024 at 1:30pm ET. A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at . About Integra LifeSciencesAt Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways ...
Integra LifeSciences Continues to Make Progress on Its ESG Strategy
Integra LifeSciences Continues to Make Progress on Its ESG Strategy The company published its third ESG report, underscoring its values and commitment to restoring lives PRINCETON, N.J., Aug. 21, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: IART), a leading global medical technology company, today issued its latest . The report highlights the company’s 2023 ESG performance and ongoing efforts against the ESG strategy and roadmap established three years ago. “Innovating treatment pathways to advance patient outcomes and set new standards of care is work that matters to our Integra colleagues ar...
Integra LifeSciences Reports Second Quarter 2024 Financial Results
Integra LifeSciences Reports Second Quarter 2024 Financial Results PRINCETON, N.J., July 29, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2024. Second Quarter 2024 Highlights Second quarter revenues of $418.2 million increased 9.7% on a reported basis and 2.3% on an organic basis compared to the prior year. Revenue increased 0.3% on an organic basis excluding Boston.Second quarter GAAP earnings per diluted share of $(0.16)...
Integra LifeSciences to Host Second Quarter 2024 Financial Results Con...
Integra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024 PRINCETON, N.J., July 15, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: IART), a leading global medical technology company, will release second quarter 2024 financial results on Monday, July 29, 2024, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at . For those planning to participate on the call, register to receive dial-in d...
Integra LifeSciences Provides Updated Plans for Its Manufacturing Faci...
Integra LifeSciences Provides Updated Plans for Its Manufacturing Facility in Braintree, Massachusetts The company plans on operationalizing this new state-of-the-art facility in the first half of 2026 PRINCETON, N.J., July 15, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: IART), a leading global medical technology company, is announcing its plans to restart the manufacture of PriMatrix® and SurgiMend® at its new manufacturing facility in Braintree, Massachusetts. The Company expects to operationalize this new facility in the first half of 2026. Since receiving the third-party audit finding...
- Jonathan Moreland
UEC URANIUM ENERGY CORP
TCBI TEXAS CAPITAL BANCSHARES INC.
NCLH NORWEGIAN CRUISE LINE HOLDINGS LTD.
IART INTEGRA LIFESCIENCES HOLDINGS CORPORATION
HEAR TURTLE BEACH CORP
CTRN CITI TRENDS INC.
BERY BERRY GLOBAL GROUP INC
BCRX BIOCRYST PHARMACEUTICALS INC.
AXS AXIS CAPITAL HOLDINGS LIMITED
ACTG ACACIA RESEARCH CORP. - ACACIA TECHNOLOGIES
CECE CECO ENVIRONMENTAL CORP.
INVE INDENTIV
LEG LEGGETT & PLATT INCORPORATED
INFU INFUSYSTEMS HOLDINGS INC.
ARKR ARK RESTAURANTS CORP.
AFB ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND
DMLP DORCHESTER MINERALS L.P.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
BOMN BOSTON OMAHA
NWPP NEW PEOPLES BANKSHARES INC.
EAF GRAFTECH INTERNATIONAL
ELAN ELANCO ANIMAL HEALTH INC.
ALLO ALLOGENE THERAPEUTICS
REKR REKOR SYSTEMS
PHGE BIOMX INC
PCB PACIFIC CITY FINANCIAL CORP
TLS TELOS
FTHM FATHOM HOLDINGS
COOK TRAEGER
AUID INC.
TMCI IPSIDY INC.
HUMA TREACE MED CONCEPTS INC
FLYW HUMACYTE INC
MEGI FLYWIRE CORP
PFHC MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
LUXH PROFRAC HLDG CORP
ZURA LUXURBAN HOTELS INC
ABEO ZURA BIO LTD
MDRR ABEONA THERAPEUTICS INC.
VSTS_w MEDALIST DIVERSIFIED REIT INC.
BHRB VESTIS CORPORATION
TISI BURKE HERBERT FINANCIAL SERVICES CORP
AURX TEAM INC.
BKTI NUO THERAPEUTICS
INC.
BK TECHNOLOGIES
INC.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.